Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function

NCT01393964 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Lenalidomide
DRUG: Dexamethasone
DRUG: Dexamethasone
DRUG: Dexamethasone
BIOLOGICAL: Elotuzumab (BMS-901608; HuLuc63)

Sponsor

Bristol-Myers Squibb

Collaborators

[object Object]